Please send me updates by newsletter.

QuikVue Vet Case Share-episclerokeratitis

07/07/25

We are glad to share a vet case study captured by QuikVue eye imaging adaptor from Dr. Allison Fuchs.

Progress update! This is Rosy, a beautiful Airedale terrier that I showed you about a month ago. Rosy has an immune mediated ocular surface disease called episclerokeratitis, which causes inflammation in the white part of the eye (sclera) and the cornea. She was very severely affected when she first came to see me, but responded rapidly to topical immunosuppressants (steroids and tacrolimus drops). There was a big difference in just 10 days as you can see between the first and second photo! Now Rosy returned for her 1 month progress examination, and look at that! All the blood vessels on the cornea are gone and she looks amazing. She is completely off the topical steroid drops, and we’ll see if we can maintain her with just the Tacrolimus. She will require some monitoring and these patients can have flare-ups that mean increases in medication, but most can be controlled on a pretty low level which is great. 


We are glad to share a vet case study captured by QuikVue eye imaging adaptor from Dr. Allison Fuchs.

Progress update! This is Rosy, a beautiful Airedale terrier that I showed you about a month ago. Rosy has an immune mediated ocular surface disease called episclerokeratitis, which causes inflammation in the white part of the eye (sclera) and the cornea. She was very severely affected when she first came to see me, but responded rapidly to topical immunosuppressants (steroids and tacrolimus drops). There was a big difference in just 10 days as you can see between the first and second photo! Now Rosy returned for her 1 month progress examination, and look at that! All the blood vessels on the cornea are gone and she looks amazing. She is completely off the topical steroid drops, and we’ll see if we can maintain her with just the Tacrolimus. She will require some monitoring and these patients can have flare-ups that mean increases in medication, but most can be controlled on a pretty low level which is great. 


Recent Blogs

Try Digital Slit-Lamp Imaging Before You Buy: EyeStream 7-Day U.S. Trial

Try Digital Slit-Lamp Imaging Before You Buy: EyeStream 7-Day U.S. Trial

EyeStream helps clinics add digital photo, video, meibography, fluorescein-supported imaging, and VisuDoc documentation to compatible slit lamps. With the 7-day U.S. trial, clinicians can evaluate the workflow in their own exam room before making a purchase decision.

07-01,2026
MeiboVue in Sjögren's Dry Eye: Tracking Severe Gland Dropout When Symptoms Improve

MeiboVue in Sjögren's Dry Eye: Tracking Severe Gland Dropout When Symptoms Improve

After multimodal dry-eye care, symptoms may improve — but clinicians still need to know whether severe meibomian gland dropout is stable or progressing. MeiboVue supports portable baseline and follow-up meibography in pre-test or chairside flow. One de-identified case shows before/after comparison alongside qualified clinical findings.

06-23,2026
Four Cases: What AnterVue Imaging Can Help You Show

Four Cases: What AnterVue Imaging Can Help You Show

The following de-identified captures illustrate four common scleral lens scenarios. Images show visible findings for discussion—not standalone proof of fit quality or required lens changes.

06-16,2026